Around 300,000 people die from hepatitis C every year. A new study has mapped the protein complex that enables the virus to infect our cells, potentially paving the way for an effective vaccine.
Most people infected by the hepatitis C virus (HCV) can be cured with antiviral therapy, but access to the treatment remains limited. Even diagnosis of hepatitis C, a disease that causes chronic ...
Maternal hepatitis C virus (HCV) RNA titer > 10⁶ International Units (IU)/mL and antepartum bleeding are key predictors of perinatal transmission, with the risk ranging from 1.5% to 28.5%. The ...
In a study published in Scientific Reports, researchers from Spain developed a method to design vaccines for highly variable viruses like the hepatitis C virus (HCV) using combinatorial optimization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback